본문으로 건너뛰기
← 뒤로

The Function of Poly (U) Binding Splicing Factor 60 (PUF60) in Disease Regulation.

Anti-cancer agents in medicinal chemistry 2026 Vol.26(2) p. 137-146

Chen H, Guan T, Song J, Chen Y

📝 환자 설명용 한 줄

The alternative splicing (AS) of pre-mRNA is an important process in controlling the expression of human genes, which can enrich the diversity of the proteome and regulate gene function.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Chen H, Guan T, et al. (2026). The Function of Poly (U) Binding Splicing Factor 60 (PUF60) in Disease Regulation.. Anti-cancer agents in medicinal chemistry, 26(2), 137-146. https://doi.org/10.2174/0118715206346843241119105519
MLA Chen H, et al.. "The Function of Poly (U) Binding Splicing Factor 60 (PUF60) in Disease Regulation.." Anti-cancer agents in medicinal chemistry, vol. 26, no. 2, 2026, pp. 137-146.
PMID 39773058

Abstract

The alternative splicing (AS) of pre-mRNA is an important process in controlling the expression of human genes, which can enrich the diversity of the proteome and regulate gene function. On the contrary, aberrant splicing contributes significantly to numerous human diseases progression, including tumors, neurological diseases, metabolic diseases, infections, and immune diseases. The PUF60, a protein related to RNA splicing, plays critical functions in RNA splicing and gene transcription regulation. In addition, it can achieve synergistic binding with U2AF65 on RNA through interactions in the pyrimidine region, promoting the splicing of introns with weak 3'- splice sites and pyrimidine bundles. Nevertheless, an increasing amount of evidence supports that it shows a significant overexpression pattern in the vast majority of cancer cells and is crucial for embryonic development, indicating that PUF60 may hold the post of a potential therapeutic target for such diseases. These studies have significantly increased our interest in PUF60. Thus, we briefly reviewed the structural domain characteristics of the PUF60, splicing mutants of PUF60, and the roles and functions in human diseases, including various cancers, infections of bacterium and viruses, myositis, and Verheij syndrome. Furthermore, the targeted PUF60 inhibitors and boundedness of the current research were elaborated in the article. The article effectively communicates critical perception and insight, making it a precious resource for those interested in PUF60 research and treatment.

MeSH Terms

Humans; RNA Splicing Factors; Neoplasms; Animals; Alternative Splicing; Repressor Proteins

같은 제1저자의 인용 많은 논문 (5)